Načítá se...
A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme()
COVID-19 has affected millions of people. Although many drugs are in use to combat disease, there is not any sufficient treatment yet. Having critical role in propagation of the novel coronavirus (SARS-CoV-2) works Main Protease up into a significant drug target. We have performed a molecular dockin...
Uloženo v:
| Vydáno v: | Journal of the Indian Chemical Society |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Indian Chemical Society. Published by Elsevier B.V.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056978/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jics.2021.100041 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|